OCULAR MELANOMA
Clinical trials for OCULAR MELANOMA explained in plain language.
Never miss a new study
Get alerted when new OCULAR MELANOMA trials appear
Sign up with your email to follow new studies for OCULAR MELANOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy aims to supercharge immune cells against tough melanoma
Disease control Recruiting nowThis early-phase study tests a new drug (IOV-3001) designed to boost immune cells in people with advanced melanoma that has not responded to prior treatments. About 42 adults will receive the drug alongside a personalized cell therapy called lifileucel. The main goals are to chec…
Matched conditions: OCULAR MELANOMA
Phase: PHASE1, PHASE2 • Sponsor: Iovance Biotherapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New eye injection could spare sight in melanoma patients
Disease control Recruiting nowThis Phase 3 trial tests a new drug called belzupacap sarotalocan (AU-011) for people with small choroidal melanoma or suspicious spots in the eye. The drug is injected into the eye and activated by a laser to target cancer cells. The study compares it to a sham (fake) procedure …
Matched conditions: OCULAR MELANOMA
Phase: PHASE3 • Sponsor: Aura Biosciences • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
How does eye cancer treatment affect daily life? new study aims to find out
Knowledge-focused Recruiting nowThis study tracks how choroidal melanoma and its treatment affect patients' quality of life. It involves 15 people already in a larger Phase 3 trial. Participants fill out questionnaires about their well-being over two years. No new drugs or procedures are tested here.
Matched conditions: OCULAR MELANOMA
Sponsor: Aura Biosciences • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:06 UTC